Articles avec mandats d'accès public - Marc G. CaronEn savoir plus
Non disponibles : 3
Activity‐dependent expression of ELAV/Hu RBPs and neuronal mRNAs in seizure and cocaine brain
DM Tiruchinapalli, MG Caron, JD Keene
Journal of neurochemistry 107 (6), 1529-1543, 2008
Exigences : US National Institutes of Health
The role of arrestins in development
M Philipp, T Evron, MG Caron
Progress in Molecular Biology and Translational Science 118, 225-242, 2013
Exigences : US National Institutes of Health
TITLE PAGE PARACRINE MODULATION OF CHOLANGIOCYTE SEROTONIN SYNTHESIS ORCHESTRATES BILIARY REMODELING IN ADULTS
A Omenetti, L Yang, RR Gainetdinov, CD Guy, SS Choi, W Chen, ...
Exigences : US National Institutes of Health
Disponibles quelque part : 158
Akt/GSK3 signaling in the action of psychotropic drugs
JM Beaulieu, RR Gainetdinov, MG Caron
Annual review of pharmacology and toxicology 49 (1), 327-347, 2009
Exigences : US National Institutes of Health
Building a new conceptual framework for receptor heteromers
S Ferré, R Baler, M Bouvier, MG Caron, LA Devi, T Durroux, K Fuxe, ...
Nature chemical biology 5 (3), 131-134, 2009
Exigences : US National Institutes of Health
Role of GSK3β in behavioral abnormalities induced by serotonin deficiency
JM Beaulieu, X Zhang, RM Rodriguiz, TD Sotnikova, MJ Cools, ...
Proceedings of the National Academy of Sciences 105 (4), 1333-1338, 2008
Exigences : Instituts de recherche en santé du Canada
A β-arrestin 2 signaling complex mediates lithium action on behavior
JM Beaulieu, S Marion, RM Rodriguiz, IO Medvedev, TD Sotnikova, ...
Cell 132 (1), 125-136, 2008
Exigences : Howard Hughes Medical Institute, Instituts de recherche en santé du Canada
Discovery of β-arrestin–biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy
JA Allen, JM Yost, V Setola, X Chen, MF Sassano, M Chen, S Peterson, ...
Proceedings of the National Academy of Sciences 108 (45), 18488-18493, 2011
Exigences : US National Institutes of Health
N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity
NH Jensen, RM Rodriguiz, MG Caron, WC Wetsel, RB Rothman, BL Roth
Neuropsychopharmacology 33 (10), 2303-2312, 2008
Exigences : US National Institutes of Health
TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity
FG Revel, JL Moreau, RR Gainetdinov, A Bradaia, TD Sotnikova, R Mory, ...
Proceedings of the national academy of sciences 108 (20), 8485-8490, 2011
Exigences : Fonds national suisse
Antagonism of dopamine D2 receptor/β-arrestin 2 interaction is a common property of clinically effective antipsychotics
B Masri, A Salahpour, M Didriksen, V Ghisi, JM Beaulieu, RR Gainetdinov, ...
Proceedings of the National Academy of Sciences 105 (36), 13656-13661, 2008
Exigences : US National Institutes of Health, Instituts de recherche en santé du Canada
Spinal cord stimulation restores locomotion in animal models of Parkinson's disease
R Fuentes, P Petersson, WB Siesser, MG Caron, MAL Nicolelis
Science 323 (5921), 1578-1582, 2009
Exigences : US National Institutes of Health
MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction
J Kocerha, MA Faghihi, MA Lopez-Toledano, J Huang, AJ Ramsey, ...
Proceedings of the National Academy of Sciences 106 (9), 3507-3512, 2009
Exigences : US National Institutes of Health
Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands
A Kapur, P Zhao, H Sharir, Y Bai, MG Caron, LS Barak, ME Abood
Journal of Biological Chemistry 284 (43), 29817-29827, 2009
Exigences : US National Institutes of Health
Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs
C Wang, H Wu, T Evron, E Vardy, GW Han, XP Huang, SJ Hufeisen, ...
Nature communications 5 (1), 4355, 2014
Exigences : US National Institutes of Health
Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors
A Anzalone, JE Lizardi-Ortiz, M Ramos, C De Mei, FW Hopf, C Iaccarino, ...
Journal of Neuroscience 32 (26), 9023-9034, 2012
Exigences : US National Institutes of Health, Institut national de la santé et de la …
Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions
MTG Perona, S Waters, FS Hall, I Sora, KP Lesch, DL Murphy, M Caron, ...
Behavioural pharmacology 19 (5-6), 566-574, 2008
Exigences : US National Institutes of Health
The 5-HT deficiency theory of depression: perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase 2Arg439His knockin mouse
JPR Jacobsen, IO Medvedev, MG Caron
Philosophical Transactions of the Royal Society B: Biological Sciences 367 …, 2012
Exigences : US National Institutes of Health
Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor
S Espinoza, A Salahpour, B Masri, TD Sotnikova, M Messa, LS Barak, ...
Molecular pharmacology 80 (3), 416-425, 2011
Exigences : US National Institutes of Health
Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter
A Salahpour, AJ Ramsey, IO Medvedev, B Kile, TD Sotnikova, ...
Proceedings of the National Academy of Sciences 105 (11), 4405-4410, 2008
Exigences : Howard Hughes Medical Institute, Instituts de recherche en santé du Canada
Les informations concernant la publication et le financement sont déterminées automatiquement par un programme informatique